These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9710592)

  • 1. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
    Senechal K; Heaney C; Druker B; Sawyers CL
    Mol Cell Biol; 1998 Sep; 18(9):5082-90. PubMed ID: 9710592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R; Pisick E; Sattler M; Li JL; Uemura N; Wong WK; Burky SA; Hirai H; Chen LB; Griffin JD
    J Biol Chem; 1996 Oct; 271(41):25198-203. PubMed ID: 8810278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    Oncogene; 1997 Feb; 14(5):507-13. PubMed ID: 9053848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N; Salgia R; Li JL; Pisick E; Sattler M; Griffin JD
    Leukemia; 1997 Mar; 11(3):376-85. PubMed ID: 9067577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G.
    Arai A; Nosaka Y; Kohsaka H; Miyasaka N; Miura O
    Blood; 1999 Jun; 93(11):3713-22. PubMed ID: 10339478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M; Salgia R
    Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
    Sattler M; Salgia R; Shrikhande G; Verma S; Uemura N; Law SF; Golemis EA; Griffin JD
    J Biol Chem; 1997 May; 272(22):14320-6. PubMed ID: 9162067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the adapter protein CRKL in integrin-mediated adhesion.
    Uemura N; Salgia R; Ewaniuk DS; Little MT; Griffin JD
    Oncogene; 1999 Jun; 18(22):3343-53. PubMed ID: 10362355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
    Barber DL; Mason JM; Fukazawa T; Reedquist KA; Druker BJ; Band H; D'Andrea AD
    Blood; 1997 May; 89(9):3166-74. PubMed ID: 9129019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.
    Salgia R; Uemura N; Okuda K; Li JL; Pisick E; Sattler M; de Jong R; Druker B; Heisterkamp N; Chen LB
    J Biol Chem; 1995 Dec; 270(49):29145-50. PubMed ID: 7493940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
    de Jong R; van Wijk A; Heisterkamp N; Groffen J
    Oncogene; 1998 Nov; 17(21):2805-10. PubMed ID: 9840945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration.
    Uemura N; Griffin JD
    J Biol Chem; 1999 Dec; 274(53):37525-32. PubMed ID: 10608804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
    de Jong R; ten Hoeve J; Heisterkamp N; Groffen J
    J Biol Chem; 1995 Sep; 270(37):21468-71. PubMed ID: 7545163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
    Kyono WT; de Jong R; Park RK; Liu Y; Heisterkamp N; Groffen J; Durden DL
    J Immunol; 1998 Nov; 161(10):5555-63. PubMed ID: 9820532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
    Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
    Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation of murine Crkl.
    de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adapter protein CrkL associates with CD34.
    Felschow DM; McVeigh ML; Hoehn GT; Civin CI; Fackler MJ
    Blood; 2001 Jun; 97(12):3768-75. PubMed ID: 11389015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
    Sattler M; Salgia R; Shrikhande G; Verma S; Pisick E; Prasad KV; Griffin JD
    J Biol Chem; 1997 Apr; 272(15):10248-53. PubMed ID: 9092574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
    Salgia R; Li JL; Lo SH; Brunkhorst B; Kansas GS; Sobhany ES; Sun Y; Pisick E; Hallek M; Ernst T
    J Biol Chem; 1995 Mar; 270(10):5039-47. PubMed ID: 7534286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.